0001387131-14-000483.txt : 20140213 0001387131-14-000483.hdr.sgml : 20140213 20140213095404 ACCESSION NUMBER: 0001387131-14-000483 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133709558 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-82720 FILM NUMBER: 14603438 BUSINESS ADDRESS: STREET 1: 1245 BRICKYARD RD STREET 2: #590 CITY: SALT LAKE CITY, STATE: UT ZIP: 84106 BUSINESS PHONE: 347-753-4389 MAIL ADDRESS: STREET 1: 1245 BRICKYARD RD STREET 2: #590 CITY: SALT LAKE CITY, STATE: UT ZIP: 84106 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GCK Holdings Corp. CENTRAL INDEX KEY: 0001597486 IRS NUMBER: 592314283 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 4000 HOLLYWOOD BLVD. STREET 2: SUITE 530N CITY: HOLLYWOOD STATE: FL ZIP: 33021 BUSINESS PHONE: 954-985-2400 MAIL ADDRESS: STREET 1: 4000 HOLLYWOOD BLVD. STREET 2: SUITE 530N CITY: HOLLYWOOD STATE: FL ZIP: 33021 SC 13G 1 ohrgck-13g_123113.htm

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934*

 

 

 

  Ohr Pharmaceutical Inc.  
  (Name of Issuer)  
     
  Common Stock,  
  (Title of Class of Securities)  
     
  6778H200  
  (CUSIP Number)  
     
  December 31, 2013  
  (Date of Event Which Requires Filing of this Statement)  
     

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o Rule 13d-1(b)
þ Rule 13d-1(c)
o Rule 13d-1(d)

 

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

1
 

 

 

CUSIP No. 67778H200 SCHEDULE 13G

 

 

 

1

NAMES OF REPORT ING PERSON S

GCK Holdings Corp.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 5

SOLE VOTING POWER

1,819,6311

  6

SHARED VOTING POWER

0

  7

SOLE DISPOSITIVE POWER

1,819,6311

  8

SHARED DISPOSITIVE POWER

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

1,819,6311

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.1%2

12

TYPE OF REPORTING PERSON

CO

       

1. Consists of 1,521,409 shares of common stock and 298,222 warrants to purchase common stock.

2. Based on 19,970,049 shares of Common Stock of the Company outstanding at the close of business on December 27, 2013, as represented in the Company's Annual Report on Form 10-K for the Year ended September 30, 2013.

 

    

 

2
 

 

 

Item 1(a) Name of Issuer :
   
  Ohr Pharmaceutical, Inc.
   
   
Item 1(b) Address of Issuer’s Principal Executive Offices :
   
 

800 3rd Ave, 11th Floor

New York, NY 10022

   
   
Items 2(a) Name of Person Filing :
   
  This Schedule 13G is being filed by GCK Holdings Corp, a Delaware corporation.
   
   
Item 2(b) Address of Principal Business Office :
   
 

4000 Hollywood Blvd., Suite 530N

Hollywood, FL 33021

   
   
Item 2(c) Citizenship :
   
  US
   
   
  Item 2(d) Title of Class of Securities :
   
  Common Stock
   
   
Item 2(e) CUSIP Number :
   
 

67778H200

 

 

 

 

Item 3   If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a :  
         
  (a)   o Broker or dealer registered under Section 15 of the Act;  
         
  (b)   o Bank as defined in Section 3(a)(6) of the Act;  
         
  (c)    o Insurance company as defined in Section 3(a)(19) of the Act;  
         
  (d)   o Investment company registered under Section 8 of the Investment Company Act of 1940;  
         
  (e)   o An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);  
         
  (f)   o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);  


3
 

 

         
  (g)   o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);  
         
  (h)   o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);  
         
  (i)   o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;  
         
  (j)   o A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);  
         
  (k)   o Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  
         
         

 

 

 

 

4
 

 

 

 

  Item 4 Ownership :
   
  The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page hereto and is incorporated herein by reference.
 

 

oX

   
   
Item 5  Ownership of Five Percent or Less of a Class :
   
  If this statement is being filed to report the fact that as of the date hereof the Select Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:
 

 

o

   
   
Item 6  Ownership of More than Five Percent on Behalf of Another Person :
 

 

N/A

   
   
Item 7  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company :
 

 

N/A

   
   
Item 8 Identification and Classification of Members of the Group :
 

 

N/A

   
   
Item 9 Notice of Dissolution of Group :
 
N/A
   

 

 

5
 

 

 

   
Item 10 Certification :

 

         By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

       
    By: /s/ Matan Ben Aviv  
    Name: Matan Ben Aviv

 

 

 

 

     Managing Member of GCK Holding Corp  

Dated: February 13, 2014